ADIL E. SHAMOO (b. August 1, 1941) is a professor, ethicist, and foreign policy analyst and commentator.
In 1998, he founded the journal Acountability in Research, and has served as its editor-in-chief since its inception. He is on the editorial boards of several other journals, including the Drug Information Journal. From 2000-2002, he served on the advisory committee for National Human Research Protections. Although he has an extensive list of publications in the fields of biochemistry and microbiology, he is currently busied by his work as an analyst for Foreign Policy in Focus, a project of the Institute for Policy Analysis. He has also authored and co-authored many op-eds on U.S. foreign policy that have been published in newspapers across the country.
Dr. Shamoo is also currently occupied with his work in the field of ethics. In 2003, he chaired a Special Issue GlaxoSmithKline Pharamaceuticals’ Ethics Advisory Group. Dr. Shamoo was then appointed to Armed Forces Epidemiological Board (AFEB) of the Department of Defense as the ethics consultant (2003-2004). Since 1991, he has taught a graduate course at the University of Maryland entitled “Responsible Conduct of Research.” Because he served as chairman on nine international conferences in ethics in research and human research protection, he was asked to testify before a congressional committee and the National Bioethics Advisory Commission.
Dr. Shamoo has held visiting professorships at the Institute for Political Studies in Paris, France and East Carolina University.
Dr. Shamoo has been cited and/or appeared frequently in local and national media both print and television. [http://www.umaryland.edu/bmb/faculty/shamoo.html#education]
Education
10/2/01
Certificate of IRB Professional (CIP) by Council for Certification of IRB Professionals.
7/12/98-7/17/98
Patent Review Course, Patent Resources Group, Inc.
9/5/92-12/12/92
Certificate, "Regulatory Issues in Biotechnology", Office of Continuing Education, University of Maryland Baltimore County.
1/11/91-1/22/91
Molecular Biology Techniques, Medical Biotechnology Center, University of Maryland at Baltimore.
9/68-1/70
Ph.D. (Biophysics) Ph.D. Program in Biology of the City University of New York, New York, N.Y. Thesis: Intermediary Reactions Involving (Na + K)-dependent ATPase. Advisor: Dr. William A. Brodsky
1/67-6/68
Graduate Studies in Biophysics. Dept. of Physiology and Biophysics, Louisville, KY.
6/64-1/66
M.S. - (Physics) University of Louisville, Louisville, KY. Thesis: Tellurium Films in Modulated Electric Field. Advisor: Dr. Manuel Schwartz, Head of Engineering Physics Dept.
9/58-6/62
B.Sc. - (Physics) University of Baghdad, Baghdad, Iraq.
Experience (since 1995)
10/3 - Present
Professor (Secondary) in the Departement of Epidemiology and Preventive Medicine.
10/2003-8/2004
Appointed to Armed Forces Epidemiological Board (AFEB) of DOD as the ethics consultant.
3/2003 - 3/2004
Chair, the Special Issue GlaxoSmithKline Pharamaceuticals’ Ethics Advisory Group.
1/02-present
Consultant, Friends Research Institute (FRI) Baltimore, MD.
12/2000-present
Member, National Human Research Protections Advisory Committee (NHRPAC)
7/82-present
Professor, and former Chairman (79-82) Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD.
7/98-present
Member, Center for Biomedical Ethics, University of Maryland, Baltimore
7/98-present
Member, University of Maryland, Baltimore Graduate Faculty in Applied Professional Ethics.
12/96 - 12/99
Adjunct Professor, Department of Physics, East Carolina University, Greenville, North Carolina.
1/1/97 - 1/1/2000
Member, Board of Directors, Howard County Mental Health Authority (quasi - public agency), Interim Chairman of the board (elected position) 2/1/97-5/20/97
5/20/97-7/99
President (Elected annually) of the Board of Directors of Howard County Mental Health Authority, Acted as Executive Director from 2/97 to 12/97.
7/95 - 9/95
Visiting Professor, Institute of Political Studies of Paris, National Political Science Foundation, Paris, France.
7/94-6/97
Member of the Board of Directors of the National Alliance for the Mentally Ill, (Elected Position).
3/95-present
Member, Advisory Board, Science for Professionals, Inc.
5/94-present
Member of the Board of Directors of "Friends Research Institute, Inc." Baltimore, MD, a national research and philanthropic organization.
1/89-present
Private Consultant in Biotechnology Research: Planning, Evaluation and Quality Management.
Offices, Organizing Committees, and Workshops (since 1995)
8/95 - Present
Founder and a member of board of directors of: Citizens for Responsible Care and Research (CIRCARE), a national human rights organization.
2/2005 - Present
Member of Partnership for Human Research Protection (PHRP), Public Advisory Council.
7/2004 - Present
Member of the Advisory Board on Master Program in Research Ethics at Sarah Lawrence College, Bronxville, NY.
7/2004 - 2/2005
Member of the Planning Committee of Sarah Lawrence College sponsored conference on: Health Advocates in Research held on Jan 14, 2005.
5/04 - 5/2006
Chair, Ethics and Regulatory Forum of the Association of Clinical Research Professionals (ACRP).
10/2003 - 6/2004
Member of the planning Committee for the conference sponsored by OHRP/FRI/F A&M University in Orlando, Florida, March 30- April 2 , 2004.
11/2001 - 10/2002
Coordinator for Award in Excellence for Health Improvement Institute.
9/2002 - 10/2004
Judge for the Innovation award for the Award of Excellence for Health Improvement Institute.
2/2002 - 12/2002
Member of the Planning Committee of the Conference Sponsored by the Office of Research Integrity entitled: Research on Research Integrity, November 16-18, 2002, Rockville, MD.
10/21/2002
Chairman, FRI’s Human Research Protections Workshop, Washington, DC.
6/1/0
Executive Secretary and Founder of the Friends Research Institute’s Research Ethics Award.The award amount is for $10,000 to be awarded annually at the FRI’s National Ethics Conferences with a plaque.
1/1/98-1/2002
Member, Award Committee of Friends Research Institute (FRI) Inc.
11/2000-10/2002
Member, Workgroup on “Financial Relationship,” National Human Research, Protections Advisory Committee (NHRPAC).
5/5/2002
Chairman, FRI’s Workshop on Human Research Protections, San Francisco, California
6/1/2001-Present
Member, Quality Improvement Committee (QIC) of Friends Research Institute FRI) Inc.It oversees all research quality issues in addition to the two Institutional Review Boards (IRBs).
3/2001
Co-chairman, National Conference on:“Ethics of the Use of Children in Research,” May 5-7, 2002, San Francisco, California.
2/2001
Awarded Friends Research Institute’s Leadership in Ethics in Research Conferences.
2/2000-6/2000
Worked with Congressional staff of Congressman Diana DeGette and Dennis Kucinich on Human Subject Protection Action 2000.
2/8/00-2/8/00
A member of a focus group sponsored by ORI for training and education in research integrity.
5/2000
Awarded Distinguished Service Award from the Howard County Mental Health Authority, Columbia, Maryland.
5/1/2000
Certificate of Recognition from Howard County Executive for serving on the board of directors of Howard County Mental Health Authority.
4/30/2000
A one day workshop on “Ethics of the Use of Human Subjects in Research” in Collaboration with Chesapeake Research Review, Inc., for Friends Research Institute, Towson, Maryland.
6/99-Present
Co-Chairman, National Conference on: “The Business of Human Experiments: ethical, legal, and regulatory issues,” to be held November 3-5, 2000 in Baltimore, Maryland.
11/18/99-11/19/99
Member of the Planning Group on Research on Research Integrity (RRI), convened by the Office of Research Integrity (ORI) Bethesda, Maryland. The group consist of about twenty scholars and policy experts.
6/16/98
Awarded: Certificate of Appreciation from the Office of the Attorney General, State of Maryland for serving on the Attorney General’s Research Working Group.
9/20/98
Awarded an Honor Award by the National Alliance for the Mentally Ill of Howard County for serving and advocating compassionately for progress in mental health services.
2/98-present
Chairman of the National Conference on: “Research with Persons with Mental Disorders Affecting Decisional Capacity” - Response to the National Bioethics Advisory Commission’s (NBAC) Report, November 13-15, 1998.
April, 1998
Chairman of a Symposium: Forum on Responsible Conduct in Biomedical Research, sponsored by Society for Experimental Biology and Medicine, District of Columbia Section and the Interinstitute Bioethics Interest Group, The National Institutes of Health, The Lister Auditorium, The National Library of Medicine, Title of the Talk: “Introduction to Ethics in Research,” 2-5 PM, Friday, May 1, 1998.
1995 -1998
Member of the Research Working Group of the Office of the Maryland Attorney General (chaired by Jack Schwartz, J.D.) to prepare a report of how the ammend the Health Care Decision Act to include the use of human subjects in Research.
1996
Attended (Invited) and made oral presentation to the Interagency working group to Implement Recommendations of the Advisory Committee on Human Radiation Experiments. February 27, 1996, Washington, D.C.
1995
Member of the Planning Committee of the “Annual Workshop on Ethical Issues in Research,” University of Maryland Graduate School at UMAB, November 8, 1995.
1994-1995
Member of the Planning Committee of the conference on: Ethical Issues in Research Relationships between Universities and Industry” held November 3-4, 1995, Baltimore Marriott, Baltimore, Maryland.
1994-1995
Chairman of the organizing committee of the "First International Conference on Ethics in Neurobiological Research with Human Subjects" held in Baltimore, Maryland in January 7-9, 1995.
1993-1995
Co-Chairman of the organizing committee of the "Fourth Conference on Research Policies and Quality Assurance - Public Perception", Sponsored by Ares-Serona Symposia, held in Monaco June 25-28, 1995.
1991-Present
Member of the NAMI "Science Review Committee" of the National Alliance for the Mentally Ill (NAMI).
Honor Societies
April, 1965 Sigma Pi Sigma
March, 1966 Phi Kappa Phi
April, 1971 Sigma Xi
Professional Societies (since 1995)
10/03-present
Member, ACRP
11/97-present
Charter Member, American Society of the Bioethics and Humanities.
1994-present
Member, World Federation for Mental Health
3/94-present
Associate Member, The Hastings Center
5/93-11/97
International Bioethics Institute
5/89-present
American College of Sports Medicine
7/87-present
Member of the Council of Biology Editors
1/81-7/95
Member of the International Society for Heart Research
6/78-7/95
Member of Basic Science Council of American Heart Association
6/78-present
American Society of Biological Chemistry and Molecular Biology
6/75-7/97
Member of the U.S. Bioenergetics Group of the Biophysical Society
7/73-7/95
New York Academy of Sciences
6/71-6/95
Charter Member of "Membrane Biophysics Group" of the Biophysical Society
4/71-present
American Physiological Society
6/70-present
American Association for Advancement of Science
1/70-present
Biophysical Society
Journals, Editorials, Reviews, etc. (since 1995)
4/2005 - Present
Member, Editorial Board of: Drug Information Journal.
1/2003-present
Member, Advisory Board of: Clinical Trials Compliance.
9/2003-present
Member, Advisory Board of: Bioresearch Monitoring Alert.
1996 -present
Editorial Board Member of: Technology Management
1987-present
Founder and Editor-in-Chief of the journal "Accountability in Research" Gordon and Breach Science Publishers, Inc., New York
1990-present
Editorial Board Member of: Quality Assurance: Good Practice, Regulation, and Law, Academic Press, New York, N.Y., USA
1985-1995
Reviewer for the following journals: J. Membrane Biology; Science; J. General Physiology; Anal. Biochemistry; J. of Neurochemistry; Biochim. Biophys. Acta; Archives of Biochemistry and Biophysics; J. Biol. Chem.; Biochemistry.
1992-1995
Grant reviews, site visits, and study sections for NIH, NSF, Department of Energy (DOE), Office of Naval Research, US-Israel BSF, and the American Heart Association-Maryland Affiliate. Recent: Jan. 29, Ad-hoc NIEHS Contract review committee on quality assurance proposals.
Bibliography
BOOKS - EDITORSHIP AND AUTHORSHIP
15. Shamoo, A. E., and Resnik, D. B. (2003), “Responsible Conduct of
Research”, pp. 1-345, 2003, Oxford University Press.
14. Shamoo, A. E., and Khin-Maung-Gyi, F. A., (2002) Monograph on : “ Ethics of the Use of Human Subjects in Research”, pp. 1-120, Garland Publishing.
13. Shamoo, A.E., and Moreno, J., Editors (2000), “Business and Research,” Proceedings of the third National Conference on the Business of Human Experiments: Ethical, Legal, and Regulatory Issues, November 3-5, 2000, Baltimore, Maryland, pp. 1-140, Taylor & Francis, New York.
12. Shamoo, A.E., Editor (1998), Proceedings of a National Conference on: Research and Decisional Capacity—Responding to the National Bioethics Advisory Commission,” Baltimore, Maryland, Nov. 13-15, 1998, pp. 1-249, Taylor & Francis, New York.
11. Rogers, M.A., Wernicki, P.G., and Shamoo, A.E., (2000) Sport Medicine for Coaches and Athletes - Older Individuals and Athletes Over 50," pp. 1-136, Harwood Academic Publishers.
10. Ekeland, A., Crockett, L.J. and Shamoo, A.E. (2000), "Sport Medicine for Coaches and Athletes - SKIING," pp. 1-136, Harwood Academic Publishers, Switzerland.
9. Shamoo, A.E., Silberstein, C.E., and Germeroth, R.M. (2000), "Sport Medicine for Coaches and Athletes - BASEBALL," pp. 1-135, Harwood Academic Publishers, Switzerland.
8. Shamoo, A.E., (1997). Editor, “Ethics in Neurobiological Research with Human Subjects” pp. 1-335, Gordon and Breach Publishers OPA, Amsterdam, B.V., The Netherlands.
7. Shamoo, A.E., Baugher, W.H., and Germeroth, R.M. (1995). “Sports Medicine for Coaches and Athletes - SOCCER.” pp. 1-115, Harwood Academic Publisher, New York, N.Y., USA.
6. R. Verna and A. Shamoo, Editors (1994). Co-Editor, “Biotechnology Today - Challenges of Modern Medicine,” Vol. 5, pp. 1-280.
5. Shamoo, A.E., Editor (1989). "Principles of Research Data Audit," Gordon and Breach Science Publishers, Inc., pp. 1-181, New York, .
4. Shamoo, A.E., Editor (1975). Carriers and Channels in Biological Systems. Ann. New
York Acad. of Sciences 264, pp. 1-485.
3. Shamoo, A.E., Editor (1977). Membrane Toxicity, Plenum Press, New York, p. 1
2. Shamoo, A.E., Editor (1980). “Carriers and Channels in Biological Systems - Transport Proteins.” Ann. New York Acad. of Sciences 358.
1. Shamoo, A.E., Editor (1985). “Regulation of Calcium Transport Across Muscle Membranes - Current Topics in Membranes and Transport,” Vol. 25, Academic Press, New York.
ARTICLES (Since 2000)
206. Shamoo, A. E. (2005), “The Need for Better Reporting of Adverse Events for Human Subjects in Research”, DIA Today, April 2005, Volume 5, Issue 2, p. 18, 20.
205. Resnik, D. B. and Shamoo, A. E., (2005) “ Bioterrrorism and the Responsible Conduct of Research”, Commentary, Drug Development Research, 63:121-133.
204. Shamoo, A. E. and Cole, J. (2004), “Ethics of Genetic Modification of Behaviour”, Accountability in Research, 11:201-214.
203. Shamoo, A. E. and Strause, L. (2004) “Closing the Gap in Regulations for the Protection of Human subjects in Research”, Monitor, Spring 2004, chosen as cover story.
202. Shamoo, A. E. and Moreno, J. (2004) “ A Response to Commentators on “Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon”, American Journal of Bioethics 4:W 29.
201. Shamoo, A.E. and Moreno, J. (2004), “Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon,” American Journal of Bioethics 4:25-31, (Chosen as a Target Article with 13 commentaries).
200. Shamoo, A.E., and Cole, J.W. (2004), “Fear of Influence - Conflict of Interest in Biomedical and Genetic Research,” In: GenWatch 13:12-13, July-August (Both in the magazine and website).
199. Shamoo, A.E. (2005), “Accountability in Research,” In: Encyclopedia of Science, Technology, and Ethics, edited by Carl Mitcham, Macmillan Publishing Company.
198. Shamoo, A.E. (2003), “A Perspective on Current Events in Vaccine Development,” In: Vaccine Technology and Development News, 2(7):10-12.
197. Shamoo, A.E., and Campbell, J.D., (2003), “The Use of Experimental Drugs During National Crises,” Accountability in Research, 10:69-84, 2003.
196. Shamoo, A.E., and Tauer, C.A. (2002), “Ethically Questionable Research with Children: The Fenfluramine Study,” Accountability in Research, 9:143-166,2002.
195. Shamoo, A.E. (2002), “Ethically Questionable Research with Children. The Kennedy Krieger Lead Abatement Study,” Accountability in Research, 9:167-175, 2002.
194. Shamoo, A. E. (2002), “Moral and Compliance Issues in Clinical Research- Part 1, Where We Are Today, RAPS RA Interactive (pp1-2), http:///www.raps.org/rainteractive/articleCT.cfm?article_ID63, Part 2, Future Challenges, RAPS RA Interactive (pp1-2, http:///www.raps.org/rainteractive/articleCT.cfm?article_ID70
193. Shamoo, A.E., Krimsky, S., and Resnik, D.B., (2002), “Editorial,” Accountability in Research, 8:281-282.
192. Shamoo, A.E. (2001), “Adverse Events Reporting - The Tip of an Iceberg,” Accountability in Research, 8:197-218.
191. Shamoo, A. E. (2000), “ Editorial: The Ethical Import of Cold Fusion Controversy”, Accountability in Research, 8:i-iv.
190. Sharav V. H., and Shamoo, A. E. (2000), “ Lab Rats- Why do people who participate in clinical studies have fewer protections than animals”, Salon.Com, August 21, (http://www.salon.com/health/feature/2000/08/18/human_subject.htm)
189. Shamoo, A. E. and Cheryl Dunigan (2000), “ Ethics in Research”, Experimental Biology and Medicine 224:205-210.
188. Sharav, V. H., and Shamoo, A. E. (2000), "Are Experiments That Chemically Induce Psychosis In Patients Ethical?”, BioLaw, II, No.1: S1-S36.
187. Shamoo, A.E. (2000), " Future Challenges to Human Subject Protection", The Scientist, June 26, 35-35.
186. Shamoo, A.E. (2000), “Ethics of High Risk Psychiatric Research,” Winter Trauma, pp. 13 & 14.
185. Shamoo, A.E. (1999), "Critique of the Recommendations of the National Bioethics Advisory Commission's Report on Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity," BioLaw II, Nos. 9 & 10:S439-S444.
184. Sharav, V.H. and Shamoo, A.E. (1999). “Unethical Human Experiments in Unwitting Patients,” Statement for the Record submitted to U.S. Senate Sub-Committee, Public Health and Safety of the Senate Health, Education, Labor and Pensions Committee, February 2, 2000.
|
|
|
